Eugenia Piras

1.0k total citations
19 papers, 698 citations indexed

About

Eugenia Piras is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eugenia Piras has authored 19 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Genetics and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eugenia Piras's work include Hematopoietic Stem Cell Transplantation (12 papers), Hemoglobinopathies and Related Disorders (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Eugenia Piras is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Hemoglobinopathies and Related Disorders (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Eugenia Piras collaborates with scholars based in Italy, United Kingdom and Iraq. Eugenia Piras's co-authors include Giorgio La Nasa, Giovanni Caocci, Adriana Vacca, Roberto Littera, Franco Locatelli, Carlo Carcassi, Fabio Efficace, Maria Ester Bernardo, Angela Mastronuzzi and Giovanna Giorgiani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Eugenia Piras

18 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugenia Piras Italy 12 448 428 260 127 101 19 698
Adriana Vacca Italy 13 536 1.2× 538 1.3× 306 1.2× 146 1.1× 141 1.4× 25 873
Laurence Dedeken Belgium 12 300 0.7× 281 0.7× 185 0.7× 252 2.0× 19 0.2× 32 651
Mitiko Murao Brazil 14 134 0.3× 254 0.6× 200 0.8× 194 1.5× 39 0.4× 37 563
Eleonor Tiblad Sweden 18 103 0.2× 326 0.8× 426 1.6× 97 0.8× 173 1.7× 44 803
Jane Sande United States 9 127 0.3× 207 0.5× 141 0.5× 70 0.6× 26 0.3× 9 538
Simone Martins de Castro Brazil 13 201 0.4× 190 0.4× 110 0.4× 39 0.3× 11 0.1× 43 476
Francesca Ronco Italy 14 179 0.4× 386 0.9× 57 0.2× 156 1.2× 36 0.4× 40 536
Prasad Rao Koduri United States 14 151 0.3× 260 0.6× 69 0.3× 19 0.1× 85 0.8× 27 491
John M. Bowman Canada 13 134 0.3× 454 1.1× 342 1.3× 31 0.2× 57 0.6× 35 705
Karlene Mason Jamaica 16 924 2.1× 816 1.9× 339 1.3× 28 0.2× 18 0.2× 38 1.2k

Countries citing papers authored by Eugenia Piras

Since Specialization
Citations

This map shows the geographic impact of Eugenia Piras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Piras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Piras more than expected).

Fields of papers citing papers by Eugenia Piras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Piras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Piras. The network helps show where Eugenia Piras may publish in the future.

Co-authorship network of co-authors of Eugenia Piras

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Piras. A scholar is included among the top collaborators of Eugenia Piras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Piras. Eugenia Piras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Costa, Alessandro Nanni, Federica Pilo, Matteo Piga, et al.. (2025). VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management. Annals of Hematology. 104(1). 253–262. 2 indexed citations
2.
Costa, Alessandro Nanni, Federica Pilo, Eugenia Piras, et al.. (2025). Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms. Frontiers in Oncology. 15. 1563990–1563990.
3.
Mulas, Olga, Fabio Efficace, Maria Grazia Orofino, et al.. (2023). Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation. Journal of Clinical Medicine. 12(18). 6047–6047. 3 indexed citations
4.
Caocci, Giovanni, Maria Grazia Orofino, Adriana Vacca, et al.. (2017). Long‐term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment. American Journal of Hematology. 92(12). 1303–1310. 44 indexed citations
5.
Nasa, Giorgio La, Adriana Vacca, Roberto Littera, et al.. (2016). What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics. Mediterranean Journal of Hematology and Infectious Diseases. 8(1). 2016048–2016048. 10 indexed citations
6.
Caocci, Giovanni, Ernesto d’Aloja, Fabio Efficace, et al.. (2014). Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. Philosophy Ethics and Humanities in Medicine. 9(1). 13–13. 5 indexed citations
7.
8.
Nasa, Giorgio La, Giovanni Caocci, Fabio Efficace, et al.. (2013). Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood. 122(13). 2262–2270. 80 indexed citations
9.
Caocci, Giovanni, Fabio Efficace, Francesca Ciotti, et al.. (2012). Health related quality of life in Middle Eastern children with beta-thalassemia. PubMed. 12(1). 6–6. 87 indexed citations
10.
Bernardo, Maria Ester, Eugenia Piras, Adriana Vacca, et al.. (2012). Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood. 120(2). 473–476. 125 indexed citations
11.
12.
Caocci, Giovanni, Giorgio La Nasa, Ernesto d’Aloja, et al.. (2011). Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. BMC Medical Ethics. 12(1). 4–4. 13 indexed citations
13.
Locatelli, Franco, Roberto Littera, Daria Pagliara, et al.. (2011). OUTCOME of Unrelated DONOR BONE MARROW TRANSPLANTATION for THALASSEMIA MAJOR PATIENTS. Blood. 118(21). 149–149. 7 indexed citations
14.
Caocci, Giovanni, Fabio Efficace, Francesca Ciotti, et al.. (2010). Prospective Assessment of Health-Related Quality of Life in Pediatric Patients with Beta-Thalassemia following Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(6). 861–866. 50 indexed citations
15.
16.
Bernardo, Maria Ester, Marco Zecca, Eugenia Piras, et al.. (2008). Treosulfan‐based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. British Journal of Haematology. 143(4). 548–551. 48 indexed citations
17.
Nasa, Giorgio La, Roberto Littera, Franco Locatelli, et al.. (2007). The human leucocyte antigen‐G 14‐basepair polymorphism correlates with graft‐versus‐host disease in unrelated bone marrow transplantation for thalassaemia. British Journal of Haematology. 139(2). 284–288. 44 indexed citations
18.
Nasa, Giorgio La, Roberto Littera, Franco Locatelli, et al.. (2007). Status of Donor-Recipient HLA Class I Ligands and Not the KIR Genotype Is Predictive for the Outcome of Unrelated Hematopoietic Stem Cell Transplantation in Beta-Thalassemia Patients. Biology of Blood and Marrow Transplantation. 13(11). 1358–1368. 26 indexed citations
19.
Nasa, Giorgio La, F Argiolu, Claudio Giardini, et al.. (2005). Unrelated Bone Marrow Transplantation for β‐Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant Group. Annals of the New York Academy of Sciences. 1054(1). 186–195. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Vacca Breakdown of academic impact, for papers by Laurence Dedeken Breakdown of academic impact, for papers by Mitiko Murao Breakdown of academic impact, for papers by Eleonor Tiblad Breakdown of academic impact, for papers by Jane Sande Breakdown of academic impact, for papers by Simone Martins de Castro Breakdown of academic impact, for papers by Francesca Ronco Breakdown of academic impact, for papers by Prasad Rao Koduri Breakdown of academic impact, for papers by John M. Bowman Breakdown of academic impact, for papers by Karlene Mason
Rankless by CCL
2026